Xbryk 120 mg/1.7 ml
Xbryk 120 mg/1.7 ml is a medicine authorised by Swissmedic under authorisation number 69874. The authorisation holder is Samsung Bioepis CH GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 March 2025 and the authorisation is limited until 20 March 2030. ATC code M05BX04 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 69874 |
|---|---|
| Name | Xbryk 120 mg/1.7 ml |
| Full name | Xbryk 120 mg/1.7 ml, Injektionslösung |
| Authorisation holder | Samsung Bioepis CH GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | M05BX04 |
| First authorisation | 21 March 2025 |
| Authorisation validity | 20 March 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xbryk 120 mg/1.7 ml, Injektionslösung | A | 21 March 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | M05BX04 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xbryk 120 mg/1.7 ml authorised in Switzerland?
Yes. Xbryk 120 mg/1.7 ml is authorised by Swissmedic under authorisation number 69874, data as of 01 September 2026. The authorisation is limited until 20 March 2030.
Which dispensing category does Xbryk 120 mg/1.7 ml have?
Xbryk 120 mg/1.7 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Xbryk 120 mg/1.7 ml?
The authorisation holder is Samsung Bioepis CH GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.